Skip to main content
A

Abselion

The startup develops biosensor technologies that enable the analysis of proteins and small molecules in pharmaceutical research and manufacturing. Its diagnostic analyzers and kits facilitate rapid and sensitive biomolecular interaction assessments, providing near real-time medical diagnostics for researchers.

Cambridge, United Kingdom232K+ followers
Updated 2 months ago

Funding

$12.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

MV
Funding rounds are not available yet.

Founders

Product

Features

  • The startup develops biosensor technologies that enable the analysis of proteins and small molecules in pharmaceutical research and manufacturing. Its diagnostic analyzers and kits facilitate rapid and sensitive biomolecular interaction assessments, providing near real-time medical diagnostics for researchers.
This profile is AI-generated and may contain inaccuracies.